Ocular Therapeutix OCUL Long Term Notes Payable
Long Term Notes Payable at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:LongTermNotesPayable.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's long term notes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's long term notes payable?
- Ocular Therapeutix (OCUL) reported long term notes payable of $72.06M in Q1 2026.
- How has Ocular Therapeutix's long term notes payable changed year-over-year?
- Ocular Therapeutix's long term notes payable increased by 4.1% year-over-year, from $69.2M to $72.06M.
- What is the long-term trend for Ocular Therapeutix's long term notes payable?
- Over 5 years (2020 to 2025), Ocular Therapeutix's long term notes payable has grown at a 33.3% compound annual growth rate (CAGR), from $16.94M to $71.34M.